Ecovia Bio, an advanced biotechnology company specializing in sustainable biopolymer ingredients, has closed a Series B funding round led by Pointe Angels, a Detroit-area angel investor group. The capital will fund a major expansion at the company’s Livonia, Michigan facility.
The expansion addresses surging global demand for Ecovia Bio’s AzuraBase and AzuraGel product families. These gamma polyglutamic acid (γ-PGA) and specialty biopolymers serve cosmetics, personal care, agriculture, and hygiene applications. They offer an alternative to conventional superabsorbent polymers (SAPs), which are synthetic, petroleum-based plastics commonly found in diapers, feminine hygiene products, and personal care items.
Traditional SAPs persist in landfills for centuries. They break down into microplastics that contaminate soil, water, and food chains. Recent studies have detected microplastics in human blood, lungs, and placental tissue. Ecovia Bio’s biodegradable γ-PGA technology provides a solution that performs comparably without environmental or health risks.
The company’s approach addresses growing regulatory pressures and consumer demand for safer products. By scaling production, Ecovia Bio is enabling manufacturers to shift toward truly sustainable alternatives that don’t compromise on performance.
The Series B investment will increase production capacity, with the company projecting full operational capacity by 2028. Ecovia Bio has already begun evaluating additional production sites to accommodate demand beyond that timeline and ensure supply chain security for global partners.
Kousay Said, CEO of Ecovia Bio, said the funding enables the company to meet immediate customer demand while building infrastructure to serve the hygiene sector at industrial scale.
David Bloom, Executive Director of Pointe Angels, praised the management team’s technical achievement. He highlighted their disciplined capacity planning and ability to serve multiple markets from a single platform. Bloom expressed confidence the investment would strengthen Michigan’s position in biotechnology and advanced manufacturing.
The post Ecovia Bio secures Series B funding to expand biopolymer production capacity appeared first on World Bio Market Insights.
